Juliana Garaizar’s removal marks the second time in the past 12 months that TMC’s leadership is making executive changes at…More
Several FDA approvals – including ones going against AdCom votes – have attracted controversy and a perception of lowered standards…More
The agency said Friday that it had approved Celgene’s Inrebic (fedratinib), the first new drug approved for the disease –…More
Cigna’s sharpened focus on healthcare is evidenced by a number of recent moves, including, most notably its $54 billion acquisition…More
The company offers personalized 3-D printed clear aligners – essentially a form of transparent plastic braces – in a direct…More
Exo Imaging recently raised $35 million in a Series N round to transform the portable ultrasound market in which healthcare…More
Subsidiary AveXis said the two executives being replaced had not been involved in operations since May and were no longer…More
Rolling out the ratings nationwide is part of the Trump Administration’s larger initiative to inject cost and quality transparency into…More
Highmark Health is turning its internal VITAL Innovation program into a commercial offering meant to help startups test their products…More
The decision stood in contrast with the agency’s highly controversial approval of Sarepta’s previous DMD drug, Exondys 51. The company’s…More
